Saturday, October 31, 2026

Facebook Stock Went Up By Over 2% So Far Today

ViaNews Editorial Team

December 7, 2020

Facebook Stock Went Up By Over 2% So Far Today
Facebook has been somewhat immune to the crisis with its shares rising 2.58% to $286.93 at 11:05 EST on Monday, after two consecutive sessions in a row of losses. The Nasdaq Stock Market is rising 0.45% to $12,520.60, after two consecutive sessions in a row of gains, on what so far seems, a somewhat positive trend trading session today. Facebook's last close was $279.70, 6.18% below its 52-week high of $304.67.

News about Facebook today

U.s., states poised to sue Facebook for monopoly abuse. According to today's article on Bloomberg Quint, "Facebook Inc. will soon be hit by federal and state antitrust lawsuits accusing the social media giant of abusing its dominance and thwarting competition, according to three people familiar with the matter."

Facebook's Sales

Facebook's sales growth is 24.7% for the present quarter and 24.6% for the next. The company's growth estimates for the present quarter and the next is 24.2% and 20.5%, respectively.

Facebook's Revenue

Year-on-year quarterly revenue growth grew by 21.6%, now sitting on 78.98B for the twelve trailing months.

Facebook's Stock Top and Bottom Yearly Value

Facebook's stock is valued at $286.93 at 11:05 EST, below its 52-week high of $304.67 and way higher than its 52-week low of $137.10.

Facebook's Moving Average

Facebook's worth is above its 50-day moving average of $276.60 and way above its 200-day moving average of $257.86.

Previous days news about Facebook

Facebook failed to put fact-check labels on 60% of the most viral posts containing Georgia election misinformation that its own fact-checkers had debunked, a new report says. According to Business Insider on Fri Dec 4, "Facebook has promised repeatedly that it would crack down on election-related misinformation."
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com